NAD+ and Tinnitus: What the Hearing-Loss Research Actually Shows

Written by the Nuvirox Research Team

Short answer: the research connects NAD+ to hearing loss prevention in mice, not to tinnitus relief in people — and those are two related but distinct things. If you're dealing with ringing in the ears and found NAD+ mentioned somewhere, it's worth understanding exactly what's been studied, because the actual research is about protecting the auditory nerve from noise damage in animals, not about quieting existing tinnitus in humans.

Tinnitus and hearing loss are related, but not the same problem

Tinnitus is the perception of sound — ringing, buzzing, or hissing — without an external source. It's often, but not always, linked to some degree of hearing loss or damage to the auditory system, particularly the inner ear (cochlea) and the nerve pathways that carry sound signals to the brain. The research discussed below is about preventing damage to those nerve pathways from loud noise exposure. It's a genuinely relevant adjacent topic, but a study that prevents hearing loss in a noise-exposed mouse is not the same as a study that reduces tinnitus symptoms in a person who already has them.

What the mouse research actually found

A 2014 study published in Cell Metabolism found that nicotinamide riboside protected mice from noise-induced hearing loss by preserving the connections (ribbon synapses) between cochlear hair cells and the auditory nerve — structures that loud noise exposure typically damages. Notably, the protective effect worked whether NR was given before or after the noise exposure, and the effect depended on a specific NAD+-activated enzyme, SIRT3. A follow-up study specifically examined the ribbon synapses after repeated noise exposure and found NR administration helped preserve cochlear morphology and promoted recovery of synapse counts, particularly protecting against a second, more severe round of noise damage. More recent work has extended this line of research to age-related hearing loss models as well, with long-term NR administration reported to slow the progression of age-related hearing loss in mice.

Why this doesn't translate directly to a tinnitus claim

There are two gaps worth being explicit about. First, this is entirely mouse research — no human trial of NAD+ precursors for hearing loss or tinnitus prevention has been published. Second, even within the animal literature, the outcome measured was hearing threshold and nerve-synapse preservation, not a tinnitus-like symptom (which is genuinely difficult to measure in an animal at all). It's scientifically reasonable to hypothesize that protecting the auditory nerve could theoretically reduce the kind of damage that sometimes leads to tinnitus, but that's an inference stacked on top of preclinical data, not a tested claim.

What actually causes tinnitus, and what to do about it

Tinnitus has many possible contributors: noise-induced hearing damage, age-related hearing loss, earwax blockage, certain medications (ototoxic drugs), temporomandibular joint (TMJ) issues, and less commonly, vascular or neurological causes. Because the underlying cause varies so much, the useful first step is an evaluation by an audiologist or ear, nose, and throat (ENT) physician, who can check for treatable causes and discuss evidence-based management approaches, which may include sound therapy, cognitive behavioral therapy for tinnitus distress, and hearing aids where hearing loss is also present.

What NAD+ won't do for tinnitus

Based on current evidence, an NAD+ precursor should not be expected to quiet existing tinnitus — that specific outcome hasn't been tested in humans or, for that matter, in animals. If tinnitus is sudden, occurs in only one ear, or comes with hearing loss, dizziness, or facial numbness, that combination warrants prompt medical evaluation rather than a wait-and-see approach with a supplement.

A newer research thread: age-related hearing loss

Beyond the original noise-induced hearing loss studies, more recent mouse research has extended into age-related hearing loss (ARHL) specifically, looking at long-term NR administration over an animal's lifespan rather than around a single noise event. Early findings suggest long-term NR administration may slow the progression of ARHL in mice by preserving cochlear NAD+ levels and reducing loss of the same ribbon synapses discussed above. This is a genuinely different research question from a single noise-exposure event — it's asking whether sustained NAD+ support affects the slow, cumulative hearing decline that happens with age — but it remains, like the rest of this research area, unconfirmed in humans.

Practical prevention, while the research develops

Regardless of what future NAD+ research finds, hearing protection remains the best-evidenced way to prevent noise-induced hearing damage and the tinnitus that can follow it: foam earplugs or earmuffs during loud activities (concerts, power tools, motorsports), following the 60/60 rule for headphone listening (60% volume, 60 minutes at a time), and stepping away from a noise source for recovery time after unavoidable loud exposure. These are low-cost, well-supported habits worth adopting whether or not an NAD+ precursor ever gets tested for this specific purpose.

Frequently asked questions

Does NAD+ protect hearing from loud concerts or headphone use?

That's the hypothesis suggested by mouse research on noise-induced hearing loss, but it hasn't been tested in humans. The best-evidenced protection against noise-induced hearing damage remains simply reducing noise exposure and using hearing protection.

Is there any human data at all on NAD+ and hearing?

Not specific to tinnitus or noise-induced hearing loss. The mouse studies referenced here are the primary evidence base, and no published human trial has tested this connection directly.

What should I do if I have new or worsening tinnitus?

See an audiologist or ENT for an evaluation. They can rule out treatable causes like earwax blockage or medication side effects, assess your hearing, and discuss management options with real evidence behind them.

Should I stop taking an NAD+ supplement if I have tinnitus?

There's no evidence it would help or worsen tinnitus specifically. If you're taking one for general cellular health reasons, that's a separate decision from tinnitus management, which should go through an audiologist or ENT.

The bottom line

NAD+'s connection to tinnitus is built on a genuinely interesting body of mouse research showing nicotinamide riboside can protect the auditory nerve from noise-induced damage — but that's a hearing-protection finding in animals, not a tinnitus-relief finding in people, and the two haven't been shown to connect directly. If tinnitus is affecting you, an audiologist or ENT evaluation is the evidence-based next step. Related reading: NAD+ and eye health and NAD+ as a nootropic.

References

1. Brown KD, Maqsood S, Huang JY, et al. Activation of SIRT3 by the NAD+ precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metab. 2014;20(6):1059-1068. PMID: 25470539.
2. Nicotinamide riboside protects noise-induced hearing loss by recovering the hair cell ribbon synapses. Hear Res. 2020. PMID: 32171805.
3. Baguley D, McFerran D, Hall D. Tinnitus. Lancet. 2013;382(9904):1600-1607. PMID: 23827090.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.